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Abstract: High-quality protein has been associated with child growth; however, the role of the amino
acid cysteine remains unclear. The aim was to measure the extent to which plasma total cysteine
(tCys) concentration is associated with anthropometric status in children aged 6–30 months living in
New Delhi, India. The study was a prospective cohort study including 2102 children. We calculated
Z-scores for height-for-age (HAZ), weight-for-height (WHZ), or weight-for-age (WAZ) according to
the WHO Child Growth Standards. We used multiple regression models to estimate the association
between tCys and the anthropometric indices. A high proportion of the children were categorized
as malnourished at enrolment; 41% were stunted (HAZ ≤ −2), 19% were wasted (WHZ ≤ −2) and
42% underweight (WAZ ≤ −2). Plasma total cysteine (tCys) was significantly associated with HAZ,
WHZ and WAZ after adjusting for relevant confounders (p < 0.001). Low tCys (≤25th percentile) was
associated with a decrease of 0.28 Z-scores for HAZ, 0.10 Z-scores for WHZ, and 0.21 Z-scores for WAZ
compared to being >25th percentile. In young Indian children from low-to-middle socioeconomic
neighborhoods, a low plasma total cysteine concentration was associated with an increased risk of
poor anthropometric status.
Keywords: wasting; stunting; underweight; child growth; low- and middle-income countries (LMIC);
malnutrition; amino acid; metabolism; pre-school children; under-5 children
1. Introduction
Child undernutrition is a significant public health problem in developing countries. It is estimated
that globally, 150.8 million children under the age of 5 are stunted and 50.5 million are wasted [1].
These forms of malnutrition are associated with adverse short- and long-term consequences for growth
and development [2–4] as well as for survival [5,6].
Young children grow rapidly and have additional nutritional demands to enhance optimal growth
and development [7]. These demands are increased by environmental influences, such as a high
burden of clinical and sub-clinical infections [8–10]. Intake of high-quality protein has been shown
to promote childhood growth [9–13] with a suggested pathway via the production of insulin-like
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growth factor I (IGF-I). Additionally, a sensing pathway, the mechanistic target of rapamycin (mTOR),
has been described, which regulates energy balance and suppresses cellular growth in the case of
amino acid deficiency [11,14]. In a study among Malawian children, stunted children had lower
serum concentrations of essential, conditionally essential, and non-essential amino acids compared
to non-stunted children [11]. However, there is no evidence that the conditionally essential amino
acid cysteine is associated with linear growth in children. Cysteine is an important component in the
structure and function of proteins and enzymes and is the rate-limiting precursor of the antioxidant
glutathione, which is involved in the prevention of cell damage and functioning of the immune
system [15].
Animal studies have shown that cysteine supplementation in mice increased growth plate
thickness through upregulation of insulin-like growth factor-I (IGF-1), and led to improvements in
different bone parameters [16]. Thus, there is a biological plausibility that cysteine supplementation
can increase IGF-1 levels in children, which can improve linear growth. If cysteine supplementation
would show to improve linear growth in children as well, this could contribute to alleviating the high
burden stunting, especially in countries such as India. However, as a first step, the association between
cysteine and linear growth should be elucidated in a child population.
Further, high cysteine levels have repeatedly been associated with adult obesity based on evidence
from cellular, animal, and epidemiological studies [17–20], but here is only scarce evidence on the
associations of low levels of cysteine and undernutrition during childhood with a few studies focusing
on edematous children [21–23], or on pregnancy outcomes such as preterm birth and low birth
weight [24,25].
In this secondary analysis, we aimed to assess to what extend plasma total cysteine (tCys)
concentration is associated with poor anthropometric status in children aged 6–30 months living in
low-to-middle socioeconomic neighborhoods of New Delhi, India.
2. Materials and Methods
2.1. Original Study
We used data from a randomized controlled trial (NCT00272116 at www.clinicaltrials.gov),
which took place from 1998 until 2000 in New Delhi, India. It evaluated the effect of daily zinc
supplementation on the incidence of acute lower respiratory tract infections and pneumonia [26].
Details are described elsewhere [26]. In brief, the trial enrolled 2482 children aged 6–30 months, living in
the community of Dakshinpuri that had around 75,000 inhabitants at the time of the study. All children
aged 6–30 months were identified through a survey. Exclusion criteria were no informed consent,
plans to move out of the study area within the next four months, the need for urgent admission to the
hospital, and a recent massive dose of vitamin A (100,000 IU for infants; 200,000 for older children).
All analyses in the current study are restricted to the group of 2102 children whose tCys concentration
and anthropometry measurements were available.
Ethical clearance for the trial was given by the All India Institute of Medical Sciences Ethics
Committee. In the main trial, written informed consent was obtained from the caretaker; permission was
also sought to store the children’s blood specimen for use in future research. All parents consented to
this. All activities were performed in accordance with the Declaration of Helsinki.
2.2. Measurements
All measurement procedures were described in a manual, and standardization exercises were
done every three months. Supervisors monitored all field workers’ activities and independently
checked data collection (1% of visits).
Anthropometric measurements and non-fasting venous blood samples were taken at enrollment
and the end of the study, i.e., exactly four months after enrollment. Weight was measured with
electronic scales (seca), reading to the nearest 100 g. Length (or height for children ≥ 24 months) was
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measured with locally manufactured length boards with a precision of 0.1 cm. Heavy clothing and
nappies were removed before measurements. Blood samples (≈5 mL) were collected between 900 h
and 1200 h in heparinized polypropylene tubes (Sarstedt) by a study physician. The samples were
centrifuged, and plasma was stored immediately in polypropylene vials (Eppendorf) at −20 ◦C for
subsequent analysis. A microbiological assay with a chloramphenicol-resistant strain of Lactobacillus
casei was used to measure plasma cobalamin concentrations [27], while a colistin sulfate–resistant
strain of Lactobacillus leichmannii was used for plasma folate [28]. Measurements were done by a
robotic workstation using a microtiter plate format. Plasma methylmalonic acid (MMA), plasma total
homocysteine (tHcy) and plasma total cysteine (tCys) concentrations were measured with a modified
gas chromatography–mass spectrometry method based on ethylchloroformate derivatization [29].
The between-day coefficient of variation is reported as <5% for all assays except for tCys, where it
is ~10% [27–29]. For cobalamin, we calculated a composite measure status (3cB12) according to the
formula presented by Fedosov, et al. [30]. The composite score we used combines three biomarkers of
vitamin B12 (total B12, MMA, tHcy) and corrects for age and folate status. This is suggested to increase
the precision of the diagnosis of vitamin B12 deficiency [30]. We included 3cB12 because cobalamin is
an important factor in the transsulfuration pathway from methionine to cysteine [31].
Upon enrolment, the study physician also interviewed the caretaker including questions on
the birthdate of the child, breastfeeding practices, years of education of the parents, family size and
household income.
2.3. Data management and Analysis
Statistical analyses were done with STATA 15.0 statistical software (StataCorp, College Station,
TX) and R version 3.5.1 (R Foundation for Statistical Computing, Vienna, Austria).
We calculated Z-scores for height-for-age (HAZ), weight-for-height (WHZ) and weight-for-age
(WAZ) according to the WHO Child Growth Standards [32]. Stunting, wasting and underweight are
defined as Z-scores ≤ −2 for height-for-age, weight-for-height, and weight-for-age, respectively.
Baseline characteristics are reported as mean (SD), median (IQR) or proportion, as appropriate.
We dichotomized values for plasma cysteine at the 25th percentile because established reference values
for plasma cysteine concentrations do not exist. Differences in means, medians or proportions between
children with a tCys concentration above the 25th percentile compared to those on the 25th percentile
or below were tested with an unpaired t-test, a Wilcoxon rank-sum test or a Chi2-Test, respectively.
We built generalized estimating equation (GEE) models with anthropometric indices as outcome
and tCys concentration at enrollment as exposure. This approach uses growth data from both
time points (enrollment and 4 months later) and accounts for interdependence between multiple
measurements in the same child [33]. For continuous outcomes (HAZ, WHZ, WAZ), we used GEE
models of the Gaussian family with an identity-link function. All outcome variables were normally
distributed (skewness < 0.2). For binary outcomes (stunting, wasting, and underweight) we used
GEE models with the Poisson distribution family with a log-link function to calculate the risk ratio
(RR) [34]. For all models, we specified a robust estimator of variance and an unstructured correlation
structure. The exposure variable was tCys concentration; potential confounding variables were age (in
months), breastfeeding (yes/no), baseline plasma folate concentration, years of education of mother
and father, household income (in US$), family size, intervention group, and a composite measure
for vitamin B12 status (3cB12). In addition, we assessed an interaction between breastfeeding status
and age. All potential confounders were assessed in bivariable models, and all variables significant
at a level of 0.2 were taken into a multivariable model simultaneously. All variables not significant
at a level of 0.05 were taken out one by one and removed if the coefficient for tCys did not change
considerably (>15%). After all non-significant variables were removed from the multivariable model,
all variables initially not taken into the model, were entered one by one again and retained if now
significant (p < 0.05).
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We used generalized additive models (GAM) to depict a potential non-linear relationship between
tCys concentration and anthropometric indices (HAZ, WHZ or WAZ). We adjusted for all confounders
identified in the GEE model (of the Gaussian family) and deleted values <2.5th percentile and ≥97.5th
percentile for tCys to avoid overfitting at the extremes.
3. Results
3.1. Baseline Characteristics
Plasma total cysteine concentrations and anthropometric measurements at both time points were
available for 2102 children (Figure 1). The demographic, nutritional, and socio-economic characteristics
of the included children are summarized in Table 1. On average, children were 15 months old at
enrolment, and the majority were breastfed (69%). The families had on average five family members,
but family size varied substantially (between 2 and 19 persons living together). Fathers had on average
more years of schooling (median 8 years) than mothers (median 5 years). A high proportion of the
children were defined as malnourished at enrolment; 41% were stunted (HAZ ≤ −2), 19% were wasted
(WHZ ≤ −2) and 42% underweight (WAZ ≤ −2). At the end of the study (4 months after enrollment),
the prevalence was 46%, 20% and 43%, respectively. A display of the distribution of all anthropometric
indicators can be found in Supplementary Table S1. All characteristics shown in Table 1 differed
between those children that had a plasma cysteine concentration ≤25th percentile compared to >25
percentile, except family size, sex, and vitamin B12 concentration.
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Figure 1. Study participant flow chart.
Table 1. Baseline characteristics of 2102 children aged 6–30 months living in New Delhi, India included
in the analysis.
Characteristic All Children (n = 2102) <25th PercentileCysteine (n = 1576)
≥25th Percentile
Cysteine (n = 526)
Mean age (SD), months 15.4 (7.5) 17.0 (7.1) ** 14.8 (7.6)
Proportion male, % 52.1 49.6 53.0
Proportion breastfed, % 69.1 53.4 ** 74.3
Mean years of schooling of mother (SD) 5.2 (4.5) 4.8 (4.5) * 5.3 (4.6)
Mean years of schooling of father (SD) 8.4 (4.1) 7 8 (4.2) ** 8.6 (4.0)
Median family size (IQR) 5 (4–7) 6 (4–7) 5 (4–7)
Median annual household income (IQR), US$ 720 (480–1080) 660 (480–960) * 720 (480–1200)
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Table 1. Cont.
Characteristic All Children (n = 2102) <25th PercentileCysteine (n = 1576)
≥25th Percentile
Cysteine (n = 526)
Mean HAZ at enrolment (SD) −1.78 (1.18) −2.10 (1.19) ** −1.67 (1.16)
Mean HAZ at study end (SD) −1.92 (1.14) −2.24 (1.13) ** −1.81 (1.12)
Mean WHZ at enrolment (SD) −1.15 (1.03) −1.35 (0.98) ** −1.09 (1.03)
Mean WHZ at study end (SD) −1.19 (0.95) −1.21 (0.94) −1.18 (0.96)
Mean WAZ at enrolment (SD) −1.81 (1.09) −2.11 (1.07) ** −1.71 (1.08)
Mean WAZ at study end (SD) −1.86 (1.04) −2.06 (1.05) ** −1.80 (1.04)
Mean plasma total cysteine concentration
(SD), µmol/L 179 (25) 149 (14) 190 (19)
Median plasma cobalamin concentration
(IQR), pmol/L 206 (141–300) 213 (145–308) 204 (140–297)
Median plasma folate concentration (IQR),
nmol/L 10.6 (6.4–19.8) 7.3 (4.8–12.1) ** 12.0 (7.3–22.7)
Median plasma MMA concentration (IQR),
µmol/L 0.65 (0.37–1.29) 0.55 (0.33–1.13) * 0.67 (0.38–1.34)
Median plasma tHcy concentration (IQR),
µmol/L 10.8 (8.3–14.8) 9.6 (7.6–13.1) ** 11.2 (8.6–15.5)
Mean 3cB12 (SD) −1.03 (1.01) −0.84 (1.06) −1.09 (0.99)
* Statistically significant difference to children in ≥25th percentile category, p-value < 0.05; ** Statistically significant
difference to children in ≥25th percentile category, p-value < 0.001; Abbreviations: HAZ = height-for-age Z-score,
IQR = interquartile range, MMA = methylmalonic acid, SD = standard deviation, tHcy = total homocysteine,
WAZ = weight-for-age Z-score, WHZ = weight-for-height Z-score, 3cB12 = combined indicator for vitamin B12.
3.2. Cysteine and Undernutrition
Plasma total cysteine (tCys) at baseline was significantly associated with HAZ, WHZ, and WAZ
after adjusting for relevant confounders (p < 0.001). With one unit increase in cysteine concentration
(in µmol/L), the Z-scores for all anthropometric indicators increased by 0.003–0.005 Z-scores (Table 2;
GEE 1). The GAM plots also confirm this general trend of an increase in anthropometric status with
increasing tCys concentration (Figure 2). Having a low tCys concentrations (≤25th percentile) was
associated with a lower Z-score for HAZ (−0.28; 95% Confidence Interval (CI): −0.39, −0.18), for WHZ
(−0.10; 95% CI: −0.19, −0.01), and for WAZ (−0.21; 95% CI: −0.31, −0.11), also after adjustment for
relevant confounders (Table 2; GEE 2). In those with a low cysteine concentration (<25th percentile),
the risk was significantly higher for being stunted (Relative Risk (RR) 1.22, 95% CI: 1.12, 1.33) and
underweight (RR 1.21, 95% CI: 1.10, 1.33), respectively (Table 2; GEE 3). The risk of being wasted was
higher in those children with a low tCys, but it did not reach statistical significance when adjusted for
relevant confounders (RR 1.12, 95% CI: 0.95, 1.32).
Table 2. Association between plasma total cysteine and selected repeated anthropometric indicators
among 2102 children aged 6–30 months living in Dakshinpuri, New Delhi, India estimated in generalized
estimating equations (GEE) with robust variance estimation.
GEE 1 1 GEE 2 2 GEE 3 3
Outcome Coeff (95% CI) Coeff (95% CI) RR (95% CI)
HAZ
Unadjusted 0.0083 (0.0063, 0.0102) −0.42 (−0.53, −0.31) 1.37 (1.26, 1.50)
Adjusted 4 0.0053 (0.0034, 0.0071) −0.28 (−0.39, −0.18) 1.22 (1.12, 1.33)
WHZ
Unadjusted 0.0046 (0.0031, 0.0061) −0.16 (−0.25, −0.08) 1.17 (1.01, 1.38)
Adjusted 5 0.0034 (0.0018, 0.0049) −0.10 (−0.19, −0.01) 1.12 (0.95, 1.32)
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Table 2. Cont.
GEE 1 1 GEE 2 2 GEE 3 3
Outcome Coeff (95% CI) Coeff (95% CI) RR (95% CI)
WAZ
Unadjusted 0.0073 (0.0056, 0.0090) −0.33 (−0.43, −0.23) 1.32 (1.20, 1.44)
Adjusted 6 0.0050 (0.0033, 0.0066) −0.21 (−0.31, −0 11) 1.21 (1.10, 1.33)
1 In this GEE model, the outcome is entered as continuous Z-score (Gaussian distribution with identity link);
plasma total cysteine is entered as continuous variable (mmol/L). 2 In this GEE model, the outcome is entered as
continuous Z-score (Gaussian distribution with identity link); plasma total cysteine is entered as dichotomous
variable (≤25th percentile compared to >25th percentile). 3 In this GEE model, the outcome is entered as dichotomous
variable (≤−2 Z-scores compared to >−2 Z-scores) specified as Poisson distribution with a log link); plasma total
cysteine is entered as dichotomous variable (≤25th percentile compared to >25th percentile). 4 adjusted for age,
breastfeeding status, interaction between age and breastfeeding, mother’s education, father’s education, number
of family members, and B12 at baseline. 5 adjusted for age, breastfeeding status, interaction between age and
breastfeeding, mother’s education, number of family members, folate, and B12 at baseline. 6 adjusted for age,
breastfeeding status, interaction between age and breastfeeding, mother’s education, father’s education, number of
family members, folate, and B12 at baseline; Abbreviations: CI: confidence interval; coeff: regression coefficient;
GEE: generalized estimating equations; HAZ: height-for-age Z-score; RR: relative risk; WAZ: weight-for-age Z-score;
WHZ: weight-for-height Z-score.
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Figure 2. Generalized additive model (GAM) plots showing the relation between plasma total cysteine
(in µmol/L) and Z-scores centred around the median (left y-axis) for the anthropometric indicators
height-for-age (HAZ), weigh -for-height (WHZ) and weight-fo -age (WAZ) (solid lines), in children
aged 6–30 months living in Delhi, India. All anthropometric indicators are calculated based on the
WHO Child Growth Standards. The grey area depicts the 95% confidence interval and the dashed line
depicts the density distribution of the plasma total cysteine values (right y-axis).
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Information for this analysis was available for 85% of all the children enrolled in the original
trial. In children with no available information on anthropometry (n = 256), tCys concentration did
not differ from children with this information. Those children without information on tCys (n = 216),
had slightly higher mean Z-scores for all anthropometric indicators at baseline (HAZ, WHZ and WAZ).
Density plots can be seen in the Supplemental Material, Figure S1. All other characteristics included in
Table 1 did not differ significantly, nor did the means of the anthropometric indicators at endpoint of
the study.
4. Discussion
In our study sample of 2102 children aged 6–30 months living in low-to-middle socioeconomic
neighborhoods of New Delhi, India, plasma total cysteine (tCys) concentration was positively associated
with height-for-age (HAZ), weight-for-height (WHZ) and weight-for-age (WAZ). Children with low
tCys concentrations (≤25th percentile) had a ~20% higher risk of being stunted, or underweight.
The risk of wasting did not reach statistical significance.
The low intake of high-quality protein intake, as well as amino acid, is associated with poor
childhood growth [9–14]. In a targeted metabolomics approach, Semba and colleagues [11] showed
that 16 of 19 measured proteinogenic amino acids were significantly associated with stunting in
Malawian children. They suggested a potential biological framework through the mechanistic target
of rapamycin complex C1 (mTORC1) which has been shown to repress the synthesis of proteins,
lipids and thus limited cell growth in the absence of amino acids [14]. However, cysteine was not
included in their study and we are not aware of any other studies on linear growth in children in
relation to cysteine. In mice experiments, cysteine administration resulted in increased growth plate
thickness, probably through an upregulation of IGF-1 [16], which makes a direct effect of cysteine on
linear growth plausible. While the regression coefficients in our analysis are significant, the effect size
of GEE 1 using continuous variables can seem small; however, it needs to be emphasized that this is
not surprising for a single nutrient. It was estimated that, even if all nutrition-specific interventions
that have a solid scientific evidence base would be implemented in 90% of all children in the world,
childhood stunting would only be reduced by 20% [35]. Indeed, many interventions have had a modest
or no effect on child growth [36]. If cysteine would improve linear growth in children as shown in
the animal experiment [16], this could be a small contribution to alleviating the prevailing burden of
stunting in many countries such as India. However, further studies are needed to confirm our findings,
addressing our limitations, and to subsequently establish if a randomized supplementation would
show any effect.
The role of cysteine in kwashiorkor, a form of severe malnutrition, has been the focus in some
studies [21–23] set within the framework of the antioxidant theory proposed by Golden et al. [37].
These suggest that severely malnourished children require more cysteine as a precursor of glutathione
(GSH) for anti-oxidant defense, as a building block for acute-phase proteins or mucins for an adequate
immune response, or for gut mucosal proteins supporting to reverse the impaired gut function
associated with severe acute malnutrition [21]. However, the only randomized controlled trial
identified through a Cochrane Review [38] did not show any effects of supplementary antioxidant
micronutrients including cysteine to Malawian children on the occurrence of kwashiorkor [39].
Other relevant literature on cysteine comes from studies on growth restrictions in utero. In animal
studies, supplementing pregnant piglets with N-acetylcysteine (NAC), a precursor converted to
cysteine in the liver, prevented intra-uterine growth restriction (IUGR) [40]. The administration to
neonatal piglets with IUGR reduced mucosa damage. The authors suggest protection of the intestinal
morphology, through a reduced mitochondrial swelling and prevention of reactive oxygen species (ROS)
overproduction. Further, they suggest improvements in energy metabolism and antioxidant effects on
the intestine [41]. In studies involving humans, maternal cysteine levels have been associated with low
birth weight. One study including pregnant women found an association of low maternal cysteine
(and GSH) concentrations with pre-term birth as well as cysteine concentration in the offspring [25].
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However, other studies reported an association between high levels of maternal plasma tCys and
pre-eclampsia, pre-term birth, low birth weight, and length at birth [24,42]. We did not have any data
on pregnancy outcomes and can therefore not make any statement about the timing of the onset of the
poor anthropometric status.
The GAM plots in our work (Figure 2) show a general trend of an increase in anthropometric
Z-score (centered around the mean) with increasing tCys concentration. Although the lines are not
completely linear, they support the notion of an approximately linear relationship previously reported
in adults [43]. However, this is in contrast to a study in children aged 4–19 years, where total cysteine
was significantly associated with body fat only in overweight/obese children but not in those with
normal weight [44]. There were very few children in the upper range of weight-for-height in our
sample (7 children had a WHZ >2 at baseline).
Limitations and Strength
Data for the study come from a randomized controlled trial on zinc supplementation which limits
the generalizability. Information for this analysis was available for 85% of all the children enrolled in
the original trial. Although children without information on tCys had slightly higher mean Z-scores
for all anthropometric indicators, all other characteristics in our analysis did not differ significantly;
thus, we do not expect that missing data on tCys would bias our results considerably. The strength of
our study was that we could base our analysis of high-quality data from a community-based cohort.
This investigation was designed as an observational study, and although we considered several relevant
confounders, we cannot exclude residual confounding. Half of the children were supplemented with
zinc in this study. Although in the main trial the zinc group had a significantly reduced incidence of
diarrhea and respiratory tract infections compared to those receiving placebo [26,45], oral zinc did
not result in improved growth [46]. When included in our models, zinc supplementation was not
significantly associated with either of the anthropometric indicators, and therefore not included in the
final multivariable models.
The 10% variation in the cysteine assay is a potential limitation; however, this non-differential
misclassification in the exposure decreased the precision of our effect measure estimates and could
attenuate the observed associations between tCys and growth [47]. We used the 25th percentile as
a cut-off to indicate a low concentration of tCys. There are no recognized cut-offs for cysteine to
indicate a deficiency and therefore we based the choice on a statistical approach to capture the part of a
population with increased vulnerability. Although the GAM plots do not show any clear cut-point at
which the risk for poor anthropometric status increases, a slightly steeper curve at the left tail until
around the 25th percentile (i.e., 164 µmol/L) supports our decision.
The low intake of high-quality protein intake, as well as amino acid, is associated with poor
childhood growth [9–14]. We did not include dietary intake in this analysis, and thus, we cannot
exclude that tCys concentrations were only a marker of the overall quality of the diet and the role of
other dietary components remains unclear. Moon et al. [16] hypothesize that part of the effect of cysteine
supplementation on bone growth in mice was due to sulfur. The intake of methionine, an essential sulfur
amino acid, can affect cysteine concentrations, as it is a precursor thereof. Cysteine can replace parts of
methionine intake, but not all of it [48]. We did not have data on methionine concentrations, but we
account for its potential association through adjusting for tHcy and cobalamin in our multivariate
models, both of which are necessary for the transsulfuration pathway from methionine to cysteine.
The main source of dietary cysteine is animal source proteins [48] and diets in this population are
commonly characterized by low intake of animal products [49]. In our study, the mean (SD) tCys
concentration was 179 (25) µmol/L. There is no recognized normal range for cysteine and we did not
find any directly comparable study reporting on serum tCys concentrations. For adults, Stipanuk [48]
states that plasma tCys concentration in healthy adults would range from about 220–320 µmol/L. In a
hospital-based study among 48 pre-term neonates with gastrointestinal disease, the mean serum tCys
concentration was 153 (25), and among 288 US children who were on average 10 years old, the mean
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concentration was 193 µmol/L [44]. Cysteine dioxygenase (CDO), an enzyme involved in cysteine
catabolism, is one of the most highly regulated enzymes responding to changes in dietary intake within
hours, suggesting that cysteine homeostasis plays a central role in the human body [50]. However,
Jones, et al. [51] state that insufficient intake of sulfur amino acid (such as cysteine) over a long time
cannot be masked by recent intakes.
We did not include morbidity data in our analyses and cannot assess if cysteine concentration is
associated with ponderal and linear growth via inflammation, mucosal damage, or other morbidities.
A large part of the pediatric populations in low- and middle-income countries are affected by
environmental enteric dysfunction (EED), characterized by structural and functional changes in the
small intestines, leading to chronic inflammation and malabsorption of nutrients. EED is increasingly
recognized as a risk factor for malnutrition [52–55]. The association of cysteine with reduced oxidative
stress, inflammation and cell apoptosis, as well as improved integrity of the gut mucosa [56,57] and the
potential role thereof in the complex etiology of malnutrition, warrants further research on metabolic
alterations involving cysteine.
5. Conclusions
In our community-based population, young Indian children with a low plasma total cysteine
concentration had an elevated risk of a poor anthropometric status. Based on our results, we cannot
conclude that cysteine deficiency causes poor growth. Whether or not the association between cysteine
and growth is due to metabolic processes related to nutritional status or due to residual confounding is
not known. The role of cysteine in malnutrition should be estimated in more comprehensive studies,
including several biomarkers, dietary intake, and preferably in populations representing the whole
range of nutritional status during various critical life-cycle windows.
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